#23andme

[ follow ]
#data-breach

Hackers got nearly 7 million people's data from 23andMe. The firm blamed users in very dumb' move

Many 23andMe users are concerned about the breach of their genetic data and the potential risks it poses to their privacy and safety.
Two plaintiffs have filed a class action lawsuit against 23andMe, claiming the company failed to adequately notify users of Jewish and Chinese heritage who were allegedly targeted by hackers.

These were the badly handled data breaches of 2024 | TechCrunch

23andMe's massive data breach highlights the need for better security practices and accountability in handling user data.

23andMe failed to detect mega-breach attackers for 5 months

23andMe admitted to failing to detect malicious activity for five months during a data breach.
14,000 accounts were broken into, compromising the data of 6.9 million individuals.

These were the badly handled data breaches of 2024 | TechCrunch

Many companies continue to mishandle data breaches, repeating past mistakes instead of learning to protect user data.
23andMe and Change Healthcare exemplify poor incident responses to significant data breaches.

23andMe will pay $30 million to settle 2023 data breach lawsuit

23andMe is settling a data breach lawsuit for $30 million, committing to improved cybersecurity measures for affected users.
The company denies mishandling user data despite admitting to a major breach affecting millions.

23andMe is floundering. Here is how to delete your data.

23andMe faces major challenges including a data breach, a lawsuit settlement, and plummeting stock prices, calling consumer data security into question.

Hackers got nearly 7 million people's data from 23andMe. The firm blamed users in very dumb' move

Many 23andMe users are concerned about the breach of their genetic data and the potential risks it poses to their privacy and safety.
Two plaintiffs have filed a class action lawsuit against 23andMe, claiming the company failed to adequately notify users of Jewish and Chinese heritage who were allegedly targeted by hackers.

These were the badly handled data breaches of 2024 | TechCrunch

23andMe's massive data breach highlights the need for better security practices and accountability in handling user data.

23andMe failed to detect mega-breach attackers for 5 months

23andMe admitted to failing to detect malicious activity for five months during a data breach.
14,000 accounts were broken into, compromising the data of 6.9 million individuals.

These were the badly handled data breaches of 2024 | TechCrunch

Many companies continue to mishandle data breaches, repeating past mistakes instead of learning to protect user data.
23andMe and Change Healthcare exemplify poor incident responses to significant data breaches.

23andMe will pay $30 million to settle 2023 data breach lawsuit

23andMe is settling a data breach lawsuit for $30 million, committing to improved cybersecurity measures for affected users.
The company denies mishandling user data despite admitting to a major breach affecting millions.

23andMe is floundering. Here is how to delete your data.

23andMe faces major challenges including a data breach, a lawsuit settlement, and plummeting stock prices, calling consumer data security into question.
moredata-breach
#genetic-testing

There are no serious safeguards': can 23andMe be trusted with our DNA?

Financial troubles and plateau due to one-time DNA ancestry test offering at 23andMe
Company broadening partnerships beyond GlaxoSmithKline to leverage DNA database and generate more revenue

A Sale of 23andMe's Data Would Be Bad for Privacy. Here's What Customers Can Do.

23andMe's CEO considers selling the company, raising significant privacy concerns regarding customers' sensitive DNA data.

23andMe is on the brink. What happens to all its DNA data?

23andMe is struggling to retain customers and remains unclear about the future of the data it has collected.
The company faces significant challenges with its current business model as customer engagement declines.

23andMe sinking

23andMe experienced a dramatic decline in market value due to privacy concerns and changing public sentiment about genetic testing.

Bay Area-based 23andMe says it will delete your DNA data. But not for years.

23andMe faces significant financial challenges and privacy concerns as CEO Anne Wojcicki seeks to possibly take the company private amidst customer anxiety over data security.

23andMe cuts 40% of staff in restructuring | TechCrunch

23andMe is cutting 40% of its workforce and discontinuing its therapeutics business to focus on its core consumer operations.

There are no serious safeguards': can 23andMe be trusted with our DNA?

Financial troubles and plateau due to one-time DNA ancestry test offering at 23andMe
Company broadening partnerships beyond GlaxoSmithKline to leverage DNA database and generate more revenue

A Sale of 23andMe's Data Would Be Bad for Privacy. Here's What Customers Can Do.

23andMe's CEO considers selling the company, raising significant privacy concerns regarding customers' sensitive DNA data.

23andMe is on the brink. What happens to all its DNA data?

23andMe is struggling to retain customers and remains unclear about the future of the data it has collected.
The company faces significant challenges with its current business model as customer engagement declines.

23andMe sinking

23andMe experienced a dramatic decline in market value due to privacy concerns and changing public sentiment about genetic testing.

Bay Area-based 23andMe says it will delete your DNA data. But not for years.

23andMe faces significant financial challenges and privacy concerns as CEO Anne Wojcicki seeks to possibly take the company private amidst customer anxiety over data security.

23andMe cuts 40% of staff in restructuring | TechCrunch

23andMe is cutting 40% of its workforce and discontinuing its therapeutics business to focus on its core consumer operations.
moregenetic-testing
#layoffs

Tech layoffs update: AMD, iRobot, 23andMe, and other big firms see job losses in November 2024

Major layoffs in the tech sector persist into 2024, with significant cuts from companies like 23andMe, AMD, and iRobot.

23andMe Lays Off 200 Workers, Stops Cancer Research Program | Entrepreneur

23andMe is restructuring, resulting in major layoffs and a shutdown of its therapeutics division to focus on its core business.
The company has seen a decline in valuation and faced significant challenges in recent years, including a major data breach.

As 23andMe Crumbles, It Ceases All Efforts to Develop Drugs Using DNA Data

23andMe is restructuring, laying off 40% of its workforce, and abandoning its therapeutics program amidst severe financial struggles.

Tech layoffs update: AMD, iRobot, 23andMe, and other big firms see job losses in November 2024

Major layoffs in the tech sector persist into 2024, with significant cuts from companies like 23andMe, AMD, and iRobot.

23andMe Lays Off 200 Workers, Stops Cancer Research Program | Entrepreneur

23andMe is restructuring, resulting in major layoffs and a shutdown of its therapeutics division to focus on its core business.
The company has seen a decline in valuation and faced significant challenges in recent years, including a major data breach.

As 23andMe Crumbles, It Ceases All Efforts to Develop Drugs Using DNA Data

23andMe is restructuring, laying off 40% of its workforce, and abandoning its therapeutics program amidst severe financial struggles.
morelayoffs

DNA-testing site 23andMe fights for survival

23andMe's drastic decline highlights the importance of a sustainable business model in tech industries.
The company is under scrutiny for its handling of sensitive genetic data amidst financial struggles.
#corporate-governance

Every single member of the board just resigned from DNA tester 23andMe

23andMe is facing significant challenges, including stock plummeting and resignation of all independent directors, signaling potential decline in company viability.

23andMe appoints three former CFOs as new directors-after the previous board all resigned

Leadership turmoil at 23andMe highlighted by board resignations over strategic differences, particularly CEO Anne Wojcicki's vision for privatization.

Every Member of 23andMe's Board Except the CEO Just Resigned in Disgust

The board of directors of 23andMe resigned due to disagreements over the company's strategic direction and the CEO's management decisions.

23andMe appoints new board members as it works to stem the company's slide

23andMe appointed three new independent directors after all previous members resigned, highlighting challenges including consumer privacy concerns and declining stock values.

Every single member of the board just resigned from DNA tester 23andMe

23andMe is facing significant challenges, including stock plummeting and resignation of all independent directors, signaling potential decline in company viability.

23andMe appoints three former CFOs as new directors-after the previous board all resigned

Leadership turmoil at 23andMe highlighted by board resignations over strategic differences, particularly CEO Anne Wojcicki's vision for privatization.

Every Member of 23andMe's Board Except the CEO Just Resigned in Disgust

The board of directors of 23andMe resigned due to disagreements over the company's strategic direction and the CEO's management decisions.

23andMe appoints new board members as it works to stem the company's slide

23andMe appointed three new independent directors after all previous members resigned, highlighting challenges including consumer privacy concerns and declining stock values.
morecorporate-governance

Avoid This Former High-Flying Stock Split Stock at All Costs

Reverse stock splits like 23andMe's can indicate significant underlying issues despite a higher share price.

23andMe Is Sinking Fast. Can the Company Survive?

23andMe struggled to retain customers after initial interest due to lack of continued engagement and actionable health advice.

Bankruptcy Sale of DNA Data: From Toysmart to 23andMe

23andMe's financial struggles may lead to the sale of DNA data from its 15 million customers, raising privacy concerns.

Remember That DNA You Gave 23andMe?

23andMe's financial instability raises concerns about the potential sale of its customers' DNA data and privacy risks.
#board-resignation

23andMe Board Resigns: 'Differences' With CEO Anne Wojcicki | Entrepreneur

23andMe's board crisis reflects a struggle for strategic direction between CEO Anne Wojcicki and resigning directors amidst financial instability.

Read the memo 23andMe's cofounder sent to staff after the entire board quit

The entire board of 23andMe resigned due to differences in views with CEO Anne Wojcicki regarding plans to take the company private.

23andMe Board Resigns: 'Differences' With CEO Anne Wojcicki | Entrepreneur

23andMe's board crisis reflects a struggle for strategic direction between CEO Anne Wojcicki and resigning directors amidst financial instability.

Read the memo 23andMe's cofounder sent to staff after the entire board quit

The entire board of 23andMe resigned due to differences in views with CEO Anne Wojcicki regarding plans to take the company private.
moreboard-resignation

23andMe sees independent board directors quit en masse | TechCrunch

23andMe's declining market value and loss of investor confidence illustrate challenges faced by personal genomics companies in maintaining relevance.

Battered and bruised 23andMe faces probe after hack that stole seven million users' data

23andMe facing scrutiny following a security breach compromising 7 million users' data.
[ Load more ]